BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17009984)

  • 1. Involvement of tumor suppressor in lung cancer 1 gene expression in cervical carcinogenesis.
    Yang YX; Yang AH; Yang ZJ; Wang ZR; Xia XH
    Int J Gynecol Cancer; 2006; 16(5):1868-72. PubMed ID: 17009984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
    Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
    J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of TSLC1 gene methylation and TSLC1 protein expression in the progression of cervical lesions].
    Zhao X; Cui Y; Li Y; Liang S; Zhang Y; Xie L; Xia Z; Du J; Wei L; Li Y
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):356-60. PubMed ID: 26463026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
    Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
    Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.
    Discacciati MG; Gimenes F; Pennacchi PC; Faião-Flores F; Zeferino LC; Derchain SM; Teixeira JC; Costa MC; Zonta M; Termini L; Boccardo E; Longatto-Filho A; Consolaro ME; Villa LL; Maria-Engler SS
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1539-47. PubMed ID: 26261088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia.
    Krishnappa P; Mohamad IB; Lin YJ; Barua A
    Diagn Pathol; 2014 Nov; 9():202. PubMed ID: 25361681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression.
    Sussan TE; Pletcher MT; Murakami Y; Reeves RH
    Mol Cancer; 2005 Aug; 4():28. PubMed ID: 16083501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor.
    Houshmandi SS; Surace EI; Zhang HB; Fuller GN; Gutmann DH
    Neurology; 2006 Nov; 67(10):1863-6. PubMed ID: 17130425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.
    Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D
    Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions and clinical significances of TSLC1 and 4.1B in non-small cell lung cancer].
    Wang Z; Yang K; Wang X; Zhang J; Hao D; Chen Z
    Zhongguo Fei Ai Za Zhi; 2010 Nov; 13(11):1041-5. PubMed ID: 21081044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.
    Heller G; Geradts J; Ziegler B; Newsham I; Filipits M; Markis-Ritzinger EM; Kandioler D; Berger W; Stiglbauer W; Depisch D; Pirker R; Zielinski CC; Zöchbauer-Müller S
    Breast Cancer Res Treat; 2007 Jul; 103(3):283-91. PubMed ID: 17260099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
    Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
    Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines.
    Honda T; Tamura G; Waki T; Jin Z; Sato K; Motoyama T; Kawata S; Kimura W; Nishizuka S; Murakami Y
    Jpn J Cancer Res; 2002 Aug; 93(8):857-60. PubMed ID: 12716461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor Dlg.
    Fukuhara H; Masuda M; Yageta M; Fukami T; Kuramochi M; Maruyama T; Kitamura T; Murakami Y
    Oncogene; 2003 Sep; 22(40):6160-5. PubMed ID: 13679854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of human telomerase reverse transcriptase in high-grade intraepithelial neoplasia and carcinoma of uterine cervix and its correlation with human papillomavirus infection.
    Wang PH; Chen GD; Chang H; Yang SF; Han CP; Lin LY; Ko JL
    Reprod Sci; 2007 May; 14(4):338-48. PubMed ID: 17644806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma.
    Liu D; Feng X; Wu X; Li Z; Wang W; Tao Y; Xia Y
    Tumour Biol; 2013 Dec; 34(6):3773-83. PubMed ID: 23812766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
    Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
    Fukami T; Fukuhara H; Kuramochi M; Maruyama T; Isogai K; Sakamoto M; Takamoto S; Murakami Y
    Int J Cancer; 2003 Oct; 107(1):53-9. PubMed ID: 12925956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer.
    Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T
    Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.